Clarins Broad Spectrum Spf 15 Titanium Dioxide-sunscreen Extra-firming Foundation Tint 105 label

Clarins Broad Spectrum Spf 15 Titanium Dioxide-sunscreen Extra-firming Foundation Tint 105

Clarins Broad Spectrum Spf 15 Titanium Dioxide-sunscreen Extra-firming Foundation Tint 105 Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

  1. Ursodiol is indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. Safety of use of Ursodiol beyond 24 months is not established.
  2. Ursodiol is indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss.

History

There is currently no drug history available for this drug.

Other Information

Ursodiol is a bile acid available as 300-mg capsules suitable for oral administration.

Ursodiol is ursodiol USP (ursodeoxycholic acid), a naturally occurring bile acid found in small quantities in normal human bile and in larger quantities in the biles of certain species of bears. It is a bitter-tasting, white powder freely soluble in ethanol, methanol, and glacial acetic acid; sparingly soluble in chloroform; slightly soluble in ether; and insoluble in water. The chemical name for ursodiol is 3α,7β-dihydroxy-5β-cholan-24-oic acid (C24H40O4). Ursodiol USP has a molecular weight of 392.58. Its structure is shown below:

The chemical structure of Ursodiol.

Inactive Ingredients. Pregelatinized Starch, Colloidal Silicon Dioxide, Magnesium Stearate. The capsule shell consists of FD&C Blue #1, FD&C Red #40, FD&C Yellow #6, Titanium Dioxide, and Gelatin. The capsule imprinting ink consists of Shellac Glaze in Ethanol, Black Iron Oxide, N-Butyl Alcohol, Propylene Glycol, FD&C Blue #2 Aluminum Lake, FD&C Red #40 Aluminum Lake, FD&C Blue #1 Aluminum Lake, D&C Yellow #10 Aluminum Lake, Ethanol, and Methanol.

Clarins Broad Spectrum Spf 15 Titanium Dioxide-sunscreen Extra-firming Foundation Tint 105 Manufacturers

  • Clarins Broad Spectrum Spf 15 Titanium Dioxide-sunscreen Extra-firming Foundation Tint 105 | Marlex Pharmaceuticals Inc
    No Recall

    Clarins Broad Spectrum Spf 15 Titanium Dioxide-sunscreen Extra-firming Foundation Tint 105 | Marlex Pharmaceuticals Inc

    Clarins Broad Spectrum Spf 15 Titanium Dioxide-sunscreen Extra-firming Foundation Tint 105 | Marlex Pharmaceuticals Inc
    Gallstone Dissolution

    The recommended dose for Ursodiol treatment of radiolucent gallbladder stones is 8-10 mg/kg/day given in 2 or 3 divided doses.

    Ultrasound images of the gallbladder should be obtained at 6-month intervals for the first year of Ursodiol therapy to monitor gallstone response. If gallstones appear to have dissolved, Ursodiol therapy should be continued and dissolution confirmed on a repeat ultrasound examination within 1 to 3 months. Most patients who eventually achieve complete stone dissolution will show partial or complete dissolution at the first on-treatment re-evaluation. If partial stone dissolution is not seen by 12 months of Ursodiol therapy, the likelihood of success is greatly reduced.

    Gallstone Prevention

    The recommended dosage of Ursodiol for gallstone prevention in patients undergoing rapid weight loss is 600 mg/day (300 mg b.i.d.).